Evaluation of the Inclusion of Studies Identified by the FDA as Having Falsified Data in the Results of Meta-analyses: The Example of the Apixaban Trials

Craig A. Garmendia, Liliana Nassar Gorra, Ana Lucia Rodriguez, Mary Jo Trepka, Emir Veledar, Purnima Madhivanan

Research output: Contribution to journalLetterpeer-review

20 Scopus citations
Original languageEnglish (US)
Pages (from-to)582-584
Number of pages3
JournalJAMA Internal Medicine
Volume179
Issue number4
DOIs
StatePublished - Apr 2019
Externally publishedYes

ASJC Scopus subject areas

  • Internal Medicine

Cite this